Related references
Note: Only part of the references are listed.Effect of Influenza Vaccination of Children on Infection Rates in Hutterite Communities A Randomized Trial
Mark Loeb et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Age-Associated Decrease in TLR Function in Primary Human Dendritic Cells Predicts Influenza Vaccine Response
Alexander Panda et al.
JOURNAL OF IMMUNOLOGY (2010)
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects
Thomas R. Cate et al.
VACCINE (2010)
Influenza Virus Resistance to Antiviral Agents: A Plea for Rational Use
Gregory A. Poland et al.
CLINICAL INFECTIOUS DISEASES (2009)
Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older
Ann R. Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Human innate immunosenescence: causes and consequences for immunity in old age
Alexander Panda et al.
TRENDS IN IMMUNOLOGY (2009)
Antibody quantity versus quality after influenza vaccination
JingQi Feng et al.
VACCINE (2009)
Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults
Janet E. McElhaney et al.
VACCINE (2009)
Emerging vaccines for influenza
Pritish K. Tosh et al.
EXPERT OPINION ON EMERGING DRUGS (2008)
Rapid decline of influenza vaccine-induced antibody in the elderly: Is it real, or is it relevant?
Danuta M. Skowronski et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: A randomized controlled trial
David Holland et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Efficacy and effectiveness of influenza vaccination
Kristin L. Nichol
VACCINE (2008)
Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly
Iris de Bruijn et al.
VACCINE (2007)
Heterogeneity in vaccine immune response: The role of immunogenetics and the emerging field of vaccinomics
G. A. Poland et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
Robert B. Couch et al.
VACCINE (2007)
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy
Lone Simonsen et al.
LANCET INFECTIOUS DISEASES (2007)
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Noelle-Angelique M. Molinari et al.
VACCINE (2007)
Immunosenescence: Role and measurement in influenza vaccine response among the elderly
Paul V. Targonski et al.
VACCINE (2007)
Influenza- and RSV-associated hospitalizations among adults
John P. Mullooly et al.
VACCINE (2007)
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons
Wendy A. Keitel et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Evidence of bias in estimates of influenza vaccine effectiveness in seniors
LA Jackson et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States
RA Bright et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Antibody response to influenza vaccination in the elderly: A quantitative review
K Goodwin et al.
VACCINE (2006)
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern
RA Bright et al.
LANCET (2005)
Influenza-associated hospitalizations in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study
GJ Gorse et al.
VACCINE (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community
T Vu et al.
VACCINE (2002)
Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly
DM Murasko et al.
EXPERIMENTAL GERONTOLOGY (2002)
Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study
RM Jacobson et al.
VACCINE (2001)
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
A Podda
VACCINE (2001)
Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents
LG Rudenko et al.
VACCINE (2000)